Search Results - "GIN, Alfred S"

Refine Results
  1. 1

    Review of Eravacycline, a Novel Fluorocycline Antibacterial Agent by Zhanel, George G., Cheung, Doris, Adam, Heather, Zelenitsky, Sheryl, Golden, Alyssa, Schweizer, Frank, Gorityala, Bala, Lagacé-Wiens, Philippe R. S., Walkty, Andrew, Gin, Alfred S., Hoban, Daryl J., Karlowsky, James A.

    Published in Drugs (New York, N.Y.) (01-04-2016)
    “…Eravacycline is an investigational, synthetic fluorocycline antibacterial agent that is structurally similar to tigecycline with two modifications to the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997–2006 by Adam, Heather J, Hoban, Daryl J, Gin, Alfred S, Zhanel, George G

    “…Abstract This study evaluated the prevalence of fluoroquinolone usage and investigated the association between usage and resistance in respiratory isolates of…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Ceftazidime-Avibactam: a Novel Cephalosporin/β-lactamase Inhibitor Combination by Zhanel, George G., Lawson, Christopher D., Adam, Heather, Schweizer, Frank, Zelenitsky, Sheryl, Lagacé-Wiens, Philippe R. S., Denisuik, Andrew, Rubinstein, Ethan, Gin, Alfred S., Hoban, Daryl J., Lynch, Joseph P., Karlowsky, James A.

    Published in Drugs (New York, N.Y.) (01-02-2013)
    “…Avibactam (formerly NXL104, AVE1330A) is a synthetic non-β-lactam, β-lactamase inhibitor that inhibits the activities of Ambler class A and C β-lactamases and…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    New Lipoglycopeptides: A Comparative Review of Dalbavancin, Oritavancin and Telavancin by Zhanel, George G., Calic, Divna, Schweizer, Frank, Zelenitsky, Sheryl, Adam, Heather, Lagacé-Wiens, Philippe R. S., Rubinstein, Ethan, Gin, Alfred S., Hoban, Daryl J., Karlowsky, James A.

    Published in Drugs (New York, N.Y.) (01-05-2010)
    “…Dalbavancin, oritavancin and telavancin are semisynthetic lipoglycopeptides that demonstrate promise for the treatment of patients with infections caused by…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Ceftaroline: A Novel Broad-Spectrum Cephalosporin with Activity against Meticillin-Resistant Staphylococcus aureus by Zhanel, George G., Sniezek, Grace, Schweizer, Frank, Zelenitsky, Sheryl, Lagacé-Wiens, Philippe R. S., Rubinstein, Ethan, Gin, Alfred S., Hoban, Daryl J., Karlowsky, James A.

    Published in Drugs (New York, N.Y.) (01-01-2009)
    “…Ceftaroline is a broad-spectrum cephalosporin currently under clinical investigation for the treatment of complicated skin and skin-structure infections…”
    Get full text
    Journal Article
  11. 11
  12. 12

    The new fluoroquinolones: A critical review by Zhanel, G G, Walkty, A, Vercaigne, L, Karlowsky, J A, Embil, J, Gin, A S, Hoban, D J

    “…This paper reviews the literature available on the new fluoroquinolones - clinafloxacin, gatifloxacin, grepafloxacin, levofloxacin, moxifloxacin, sparfloxacin…”
    Get full text
    Journal Article
  13. 13

    Ceftobiprole: A Review of a Broad-Spectrum and Anti-MRSA Cephalosporin by Zhanel, George G., Lam, Ashley, Schweizer, Frank, Thomson, Kristjan, Walkty, Andrew, Rubinstein, Ethan, Gin, Alfred S., Hoban, Daryl J., Noreddin, Ayman M., Karlowsky, James A.

    Published in American journal of clinical dermatology (01-01-2008)
    “…Ceftobiprole, an investigational cephalosporin, is currently in phase III clinical development. Ceftobiprole is a broad-spectrum cephalosporin with…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Review of macrolides and ketolides: Focus on respiratory tract infections by ZHANEL, George G, DUECK, Maria, HOBAN, Daryl J, VERCAIGNE, Lavern M, EMBIL, John M, GIN, Alfred S, KARLOWSKY, James A

    Published in Drugs (New York, N.Y.) (2001)
    “…The first macrolide, erythromycin A, demonstrated broad-spectrum antimicrobial activity and was used primarily for respiratory and skin and soft tissue…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The ketolides: A critical review by ZHANEL, George G, WALTERS, Michael, NOREDDIN, Ayman, M.VERCAIGNE, Lavern, WIERZBOWSKI, Aleksandra, EMBIL, John M, GIN, Alfred S, DOUTHWAITE, Stephen, HOBAN, Daryl J

    Published in Drugs (New York, N.Y.) (2002)
    “…Ketolides are a new class of macrolides designed particularly to combat respiratory tract pathogens that have acquired resistance to macrolides. The ketolides…”
    Get full text
    Journal Article
  18. 18

    A critical review of oxazolidinones: an alternative or replacement for glycopeptides and streptogramins? by Zhanel, G G, Shroeder, C, Vercaigne, L, Gin, A S, Embil, J, Hoban, D J

    “…To review the available data on the oxazolidinones linezolid and eperezolid. Published reports were obtained by searching MEDLINE for articles published…”
    Get full text
    Journal Article
  19. 19

    Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections by Zhanel, George G, Trapp, Shannon, Gin, Alfred S, DeCorby, Mel, Lagacé-Wiens, Philippe R S, Rubinstein, Ethan, Hoban, Daryl J, Karlowsky, James A

    Published in Expert review of anti-infective therapy (01-02-2008)
    “…Two glycopeptide analogues of vancomycin and teicoplanin have been developed with improved pharmacokinetic/pharmacodynamic parameters. Dalbavancin was derived…”
    Get more information
    Journal Article
  20. 20

    A Review of New Fluoroquinolones : Focus on their Use in Respiratory Tract Infections by Zhanel, George G, Fontaine, Sonya, Adam, Heather, Schurek, Kristen, Mayer, Matt, Noreddin, Ayman M, Gin, Alfred S, Rubinstein, Ethan, Hoban, Daryl J

    “…The new respiratory fluoroquinolones (gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and on the horizon, garenoxacin) offer many improved qualities…”
    Get full text
    Journal Article